Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.67 |
| ▸ | HPGD | P15428 | 6/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.67 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | GLA | P06280 | 2/20 | 0.63 |
| ▸ | RAB9A | P51151 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | CASP3 | P42574 | 1/20 | 0.59 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.59 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.59 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.59 |
| ▸ | CNR1 | P21554 | 5/20 | 0.57 |
| ▸ | CNR2 | P34972 | 5/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.57 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30171350 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL29059536 | 1.00 | ALDH1A1 (0.67) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL12987557 | 0.89 | KDM4E (0.78) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL29435303 | 0.89 | KDM4E (0.78) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL14974877 | 0.88 | KDM4E (0.77) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL30607190 | 0.88 | KDM4E (0.77) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL12987503 | 0.88 | KDM4E (0.80) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL29435300 | 0.88 | KDM4E (0.80) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL29435304 | 0.84 | KDM4E (0.81) | ALDH1A1HPGDKDM4EKMT2AMEN1 | |
| SCHEMBL12986843 | 0.84 | KDM4E (0.81) | ALDH1A1HPGDKDM4EKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083718-A1 | PIPERIDINE UREA DERIVATIVES FOR OBESITY THERAPY | ASTRIZI BIO, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| US-20240294516-A1 | PIPERIDINE UREA DERIVATIVES AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | NeuroPn Therapeutics, Inc. (US) | 2024-09-05 | — | — | US | disclosed |
| US-20090311723-A1 | FLUORESCENCE-BASED ASSAY FOR MONOACYLGLYCEROL LIPASE COMPATIBLE WITH INHIBITOR SCREENING | WYETH (US) | 2009-12-17 | — | — | US | disclosed |
| US-20090311723-A1 | FLUORESCENCE-BASED ASSAY FOR MONOACYLGLYCEROL LIPASE COMPATIBLE WITH INHIBITOR SCREENING | WYETH (US) | 2009-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083718-A1 | PIPERIDINE UREA DERIVATIVES FOR OBESITY THERAPY | GLP1R, GIPR, GPR119 | ALDH1A1 1688/4885HPGD 3132/4885KDM4E 942/4885 |
| US-20090311723-A1 | FLUORESCENCE-BASED ASSAY FOR MONOACYLGLYCEROL LIPASE COMPATIBLE WITH INHIBITOR SCREENING | MGLL, LIPC, LIPA | ALDH1A1 676/4885HPGD 243/4885KDM4E 1535/4885 |
| US-20240294516-A1 | PIPERIDINE UREA DERIVATIVES AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS | EPHX1, EPHX2, HPGDS | ALDH1A1 241/4885HPGD 43/4885KDM4E 454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.